FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Mirtazapine Orally Disintegrating Tablets
Status: Discontinuation
»Therapeutic Categories: Psychiatry

Expand all

Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc. (New 05/29/2018)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
15mg tablets (NDC 0591-2469-15) 05/29/2018 This product discontinuation is a business related decision
30mg tablets (NDC 0591-2470-15) 05/29/2018 This product discontinuation is a business related decision
45mg tablets (NDC 0591-2471-15) 05/29/2018 This product discontinuation is a business related decision

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English